$AMP

AMP Share Price Rally Pushes RSI to Most Overbought on ASX

AMP Limited (ASX: AMP) shares rose 36.13% over the past month to A$2.11 and have gained 81.6% since March. The stock’s RSI hit 82.87, the highest on the ASX. AMP upgraded first-half 2026 underlying NPAT guidance to A$170m to A$180m and completed a A$150m buyback.

Original reporting
Published Jul 27, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 10:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMP Share Price Rally Pushes RSI to Most Overbought on ASX — source image
Decision brief

The 30-second read

$AMPBullishMed
01

Why it matters

The guidance upgrade (A$170m-A$180m underlying NPAT for 1H26) and a completed A$150m on-market buyback are presented as the fundamental drivers of the rally, while RSI 82.87 flags near-term technical exhaustion risk.

02

Market read

Traders get a single-name setup: fundamental catalyst already delivered (guidance and buyback) with a near-term technical risk (overbought RSI) ahead of the next results.

03

What to watch

The article notes profitability depends heavily on cost-cutting and that fund flows face structural headwinds, which could matter more than the technical overbought signal if flows weaken.

Relevance 7/10Novelty 6/10Timing: Ahead of AMP’s first-half 2026 results, after a guidance-led surge and RSI 82.87 overbought reading.

Background

AMP is described as transitioning from a restructuring/remediation and outflow narrative toward stabilization in wealth platform and banking operations.

Company-level read

Ticker impact

$AMPBullishMedium confidence
Context

AMP shares surged 36.13% over a month after the company upgraded its first-half 2026 profit outlook to A$170m-A$180m.

Expected impact

Near-term upside may be capped as overbought conditions raise odds of a pullback before the first-half 2026 results.

Evidence & confidence

The article cites a concrete guidance range and a completed A$150m buyback, but the only forward-looking trigger mentioned is the upcoming first-half results, while RSI 82.87 is a short-term technical risk flag.

Market effects

Could attract momentum flows into Australian financials/wealth platforms, but the article frames AMP-specific turnaround rather than a sector-wide catalyst.

Primarily ASX single-name momentum; broader ASX 200 is cited as only +0.8% over the same month.

Limited, as the catalysts and technical framing are Australia-specific and tied to AMP’s own guidance and capital actions.

Counterpoint

Overbought RSI can persist in strong trend stocks; the guidance upgrade and buyback may keep dip-buying demand active into the next earnings date.

Key entities

  • AMP Limited

    Australian wealth platform and banking operator whose 1H26 profit outlook upgrade and A$150m buyback are cited as rally drivers.

  • ASX 200

    Used as a benchmark showing the broader market rose only +0.8% over the same month.

Related articles

$AMPMed

AMP Shares At Highest Level In Years, Lead ASX 200 Gainers

AMP Ltd shares (ASX:AMP) rose 5.96% to A$2.31, near a 2018 high, after its half-year 2026 results. Assets under management grew 8.2% to $167.6B. Platforms net cash flows rose 33% to $3.1B, and Superannuation net inflows were $76M. Underlying NPAT rose 33% to $174M. Interim dividend was 3c (20% franked) and AMP plans a $150M buyback.

$AMPMedAI 8/10

Why is AMP stock surging today?

AMP shares rose 6% to a seven-year high of A$2.31 after the company reported a strong half-year. Underlying net profit after tax rose 33% to AUD 174 million, beating analyst consensus of about AUD 142 million and the company’s AUD 170–180 million guidance. Statutory NPAT rose 57% to AUD 154 million. AMP also announced a AUD 150 million buyback and raised its dividend payout ratio to 41% from 35%.

$AMPMed

AMP H1 profit jumps 57% on China partnerships, wealth gains

AMP Limited reported a 57% rise in half-year net profit to A$154 million for the six months ended June 30, driven by stronger China partnerships and wealth platforms that offset weaker banking. Revenue rose 4% to A$1.425 billion. Underlying profit increased 32.8% to A$174 million. The board declared a 3.0c interim dividend and approved an additional on-market buyback tranche up to A$150 million.

$AMPMed

40-year investor loan with 10 years of IO launches

AMP Bank launched “Equity Flex,” a 40-year loan for real estate investors with LVR up to 80%. It offers 6 to 10 years interest-only, with rates starting at 6.54% (60% LVR) and 6.59% (80% LVR), and fixed P&I at 6.39% p.a. The bank cites investor cash-flow needs amid higher rates and tax changes.

$INGMed

Home owners warned about banks’ $55 million offset account overcharging issue

Australia’s ASIC said it found weaknesses in how banks manage mortgage offset accounts, leading to overcharging interest. In a review of eight banks, ASIC reported over $55 million in compensation paid to borrowers for failures in the two years to Aug 2025, with manual errors driving 86% of failures. Offset balances were about $350 billion as of March.

$AMPMed

'Hidden' harm as ASIC finds mortgage borrowers miss out on millions in offset savings

ASIC said it found weaknesses at eight banks covering over 70% of Australia’s home-loan market in how mortgage offset accounts are set up, monitored and managed. ASIC reported banks paid more than A$55m in compensation over two years for failures that could leave borrowers paying extra interest. Banks cited include AMP, ANZ, CBA, Credit Union Australia, HSBC, ING, Macquarie and Westpac.